Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Year-over-year operating income growth rate
Latest
-42.58%
↓ 422% vs avg
Percentile
P10
Near historical low
Streak
2 qtr
Consecutive growthRecovering
Average
13.24%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -42.58% |
| Q3 2025 | -57.84% |
| Q2 2025 | -124.54% |
| Q1 2025 | 914.77% |
| Q4 2024 | 54.49% |
| Q3 2024 | -2.25% |
| Q2 2024 | -3.42% |
| Q1 2024 | 4.10% |
| Q4 2023 | -8.64% |
| Q3 2023 | 18.12% |
| Q2 2023 | -34.72% |
| Q1 2023 | 9.14% |
| Q4 2022 | -0.10% |
| Q3 2022 | -7.57% |
| Q2 2022 | -1.79% |
| Q1 2022 | -1.10% |
| Q4 2021 | -8.13% |
| Q3 2021 | -2.97% |
| Q2 2021 | -30.91% |
| Q1 2021 | -15.36% |
| Q4 2020 | -6.38% |
| Q3 2020 | -5.37% |
| Q2 2020 | -10.88% |
| Q1 2020 | -6.03% |
| Q4 2019 | -12.46% |
| Q3 2019 | -16.54% |
| Q2 2019 | -33.58% |
| Q1 2019 | -39.19% |
| Q4 2018 | -36.93% |
| Q3 2018 | -10.20% |
| Q2 2018 | -57.43% |
| Q1 2018 | 0.00% |